Surrozen, Inc. Form 8-K Summary
Business Context and Reporting Period
Surrozen, Inc. filed this Current Report on Form 8-K on March 22, 2023, under Item 2.02 to announce financial results for the year ended December 31, 2022. The filing identifies Surrozen as an emerging growth company and provides no operating or financial data beyond referencing the attached press release.
Financial Metrics
The filing text does not provide clear values for revenue, net income or loss, cash flow, margins, debt, liquidity, cash balance, or other financial metrics. Those details were reportedly included in Exhibit 99.1, the company’s March 22, 2023 press release, but the exhibit content is not included in the provided filing text.
Material Changes Versus Prior Period
The filing text does not provide a clear comparison with the prior comparable period or identify specific year-over-year changes.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided filing text. The filing states that the Item 2.02 information, including the referenced exhibit, is furnished and is not deemed filed for purposes of Section 18 of the Exchange Act.
Key Facts to Verify
- Review Exhibit 99.1 for the complete 2022 financial results and management commentary.
- Verify year-end cash, liquidity runway, operating expenses, net loss, and cash used in operations.
- Check for any disclosed debt, financing activities, clinical-development expenditures, or subsequent events.
- Confirm whether the press release contains guidance, risk factors, or material changes from 2021.